Allstate Corp Buys 16,365 Shares of GE HealthCare Technologies Inc. $GEHC

Allstate Corp grew its stake in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 100.3% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 32,688 shares of the company’s stock after purchasing an additional 16,365 shares during the quarter. Allstate Corp’s holdings in GE HealthCare Technologies were worth $2,681,000 as of its most recent SEC filing.

Several other large investors also recently modified their holdings of GEHC. Laurel Wealth Advisors LLC bought a new position in shares of GE HealthCare Technologies in the fourth quarter valued at about $26,000. Optima Capital LLC bought a new position in GE HealthCare Technologies during the fourth quarter worth about $27,000. Montag A & Associates Inc. increased its position in GE HealthCare Technologies by 105.4% during the fourth quarter. Montag A & Associates Inc. now owns 341 shares of the company’s stock worth $28,000 after acquiring an additional 175 shares during the period. Maseco LLP bought a new position in GE HealthCare Technologies during the fourth quarter worth about $29,000. Finally, Oakworth Capital Inc. increased its position in GE HealthCare Technologies by 1,876.2% during the third quarter. Oakworth Capital Inc. now owns 415 shares of the company’s stock worth $31,000 after acquiring an additional 394 shares during the period. 82.06% of the stock is owned by institutional investors.

Insider Transactions at GE HealthCare Technologies

In other news, CEO Peter J. Arduini bought 4,169 shares of the firm’s stock in a transaction on Thursday, April 30th. The shares were purchased at an average cost of $59.92 per share, with a total value of $249,806.48. Following the acquisition, the chief executive officer directly owned 259,424 shares in the company, valued at $15,544,686.08. This represents a 1.63% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Rodney F. Hochman purchased 1,618 shares of GE HealthCare Technologies stock in a transaction dated Tuesday, May 12th. The stock was bought at an average price of $62.03 per share, for a total transaction of $100,364.54. Following the completion of the purchase, the director owned 1,618 shares in the company, valued at $100,364.54. This represents a ∞ increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. Over the last quarter, insiders purchased 21,847 shares of company stock worth $1,361,355. Corporate insiders own 0.36% of the company’s stock.

GE HealthCare Technologies Price Performance

GEHC stock opened at $63.88 on Thursday. The company has a quick ratio of 0.95, a current ratio of 1.22 and a debt-to-equity ratio of 0.95. GE HealthCare Technologies Inc. has a 12 month low of $58.75 and a 12 month high of $89.77. The firm has a market cap of $29.06 billion, a P/E ratio of 15.28, a P/E/G ratio of 1.45 and a beta of 0.74. The company’s 50-day moving average price is $68.03 and its two-hundred day moving average price is $76.03.

GE HealthCare Technologies (NASDAQ:GEHC) last released its earnings results on Wednesday, April 29th. The company reported $0.99 EPS for the quarter, missing the consensus estimate of $1.07 by ($0.08). GE HealthCare Technologies had a net margin of 9.10% and a return on equity of 20.46%. The firm had revenue of $5.13 billion during the quarter, compared to the consensus estimate of $5.04 billion. During the same period in the prior year, the business earned $1.01 earnings per share. GE HealthCare Technologies’s quarterly revenue was up 7.4% compared to the same quarter last year. GE HealthCare Technologies has set its FY 2026 guidance at 4.800-5.000 EPS. On average, analysts anticipate that GE HealthCare Technologies Inc. will post 4.89 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of equities analysts recently commented on GEHC shares. Evercore set a $80.00 price target on shares of GE HealthCare Technologies in a research report on Thursday, April 30th. BNP Paribas Exane lowered their price target on shares of GE HealthCare Technologies from $95.00 to $88.00 in a research report on Friday, May 1st. Morgan Stanley raised their price target on shares of GE HealthCare Technologies from $80.00 to $85.00 and gave the stock an “equal weight” rating in a research report on Wednesday, February 4th. The Goldman Sachs Group lowered shares of GE HealthCare Technologies from a “buy” rating to a “neutral” rating and lowered their price target for the stock from $81.00 to $65.00 in a research report on Thursday, April 30th. Finally, Rothschild & Co Redburn decreased their target price on shares of GE HealthCare Technologies from $110.00 to $98.00 in a report on Thursday, April 30th. Nine equities research analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the company. Based on data from MarketBeat.com, GE HealthCare Technologies currently has a consensus rating of “Moderate Buy” and an average price target of $80.21.

About GE HealthCare Technologies

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.